All Stories

  1. Management after combined BPA and medical therapy in CTEPH: time for cardiopulmonary exercise testing

    Article • The Lancet Respiratory Medicine, July 2025, Elsevier

    Joanna Pepke-Zaba

  2. Navigating between management of pulmonary arterial hypertension and cardiometabolic and pulmonary comorbidities

    Article • The Journal of Heart and Lung Transplantation, February 2025, Elsevier

    Joanna Pepke-Zaba

  3. Impact of preoperative body mass index on long-term survival, quality of life, and functional outcomes after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: Results from the UK National Cohort

    Article • The Journal of Heart and Lung Transplantation, January 2025, Elsevier

    Joanna Pepke-Zaba

  4. The global burden of pulmonary arterial hypertension: profound but improving?

    Article • The Lancet Respiratory Medicine, January 2025, Elsevier

    Joanna Pepke-Zaba

  5. Worldwide CTEPH Registry: Long-Term Outcomes With Pulmonary Endarterectomy, Balloon Pulmonary Angioplasty, and Medical Therapy

    Article • Circulation, October 2024, Wolters Kluwer Health

    Joanna Pepke-Zaba

  6. Efficacy and safety of selexipag in patients with inoperable or persistent/recurrent CTEPH (SELECT randomised trial)

    Article • European Respiratory Journal, September 2024, European Respiratory Society (ERS)

    Joanna Pepke-Zaba

  7. Pulmonary hypertension associated with lung diseases

    Article • European Respiratory Journal, August 2024, European Respiratory Society (ERS)

    Joanna Pepke-Zaba

  8. CTEPH is an uncommon complication of COVID-19: UK national surveillance and observational screening cohort studies

    Article • European Respiratory Journal, July 2024, European Respiratory Society (ERS)

    MD Pilar Rivera Ortega, Joanna Pepke-Zaba

  9. Shared and Distinct Genomics of Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Embolism

    Article • American Journal of Respiratory and Critical Care Medicine, June 2024, American Thoracic Society

    Joanna Pepke-Zaba

  10. The Digital 1-Minute Walk Test: A New Patient-centered Cardiorespiratory Endpoint

    Article • American Journal of Respiratory and Critical Care Medicine, March 2024, American Thoracic Society

    Joanna Pepke-Zaba

  11. Pulmonary Embolism (PE) to Chronic Thromboembolic Pulmonary Disease (CTEPD): Findings from a Survey of UK Physicians

    Article • Advances in respiratory medicine, January 2024, MDPI AG

    Joanna Pepke-Zaba

  12. Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertension

    Article • Nature Communications, January 2024, Springer Science + Business Media

    Joanna Pepke-Zaba

  13. Chronic Thromboembolic Pulmonary Hypertension: A Review of the Multifaceted Pathobiology

    Article • Biomedicines, December 2023, MDPI AG

    Joanna Pepke-Zaba

  14. Oral Treprostinil is Associated with Improved Survival in FREEDOM-EV and its Open-Label Extension

    Article • Advances in Therapy, December 2023, Springer Science + Business Media

    Joanna Pepke-Zaba

  15. Predictors of outcomes in mild pulmonary hypertension according to 2022 ESC/ERS Guidelines: the EVIDENCE-PAH UK study

    Article • European Heart Journal, August 2023, Oxford University Press (OUP)

    Joanna Pepke-Zaba

  16. Illuminating the many faces of pulmonary hypertension

    Article • The Lancet Respiratory Medicine, August 2023, Elsevier

    Joanna Pepke-Zaba

  17. European Society of Cardiology quality indicators for the care and outcomes of adults with pulmonary arterial hypertension. Developed in collaboration with the Heart Failure Association of the European Society of Cardiology

    Article • European Journal of Heart Failure, April 2023, Wiley

    Joanna Pepke-Zaba

  18. Angiopoietin 2 and hsCRP are associated with pulmonary hemodynamics and long-term mortality respectively in CTEPH—Results from a prospective discovery and validation biomarker study

    Article • The Journal of Heart and Lung Transplantation, March 2023, Elsevier

    Joanna Pepke-Zaba

  19. Corrigendum to: 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respir...

    Article • European Heart Journal, February 2023, Oxford University Press (OUP)

    Joanna Pepke-Zaba

  20. Right ventricular–pulmonary artery coupling in chronic thromboembolic pulmonary hypertension

    Article • Heart, December 2022, BMJ

    Joanna Pepke-Zaba

  21. First Genotype–Phenotype Study in TBX4 Syndrome: Gain-of-Function Mutations Causative for Lung Disease

    Article • American Journal of Respiratory and Critical Care Medicine, December 2022, American Thoracic Society

    Joanna Pepke-Zaba

  22. Conduction disease in IPAH: prevalence and clinical implications

    Article • September 2022, European Respiratory Society (ERS)

    Joanna Pepke-Zaba

  23. Prevalence and clinical significance of conduction disease in patients with idiopathic pulmonary arterial hypertension

    Article • The Journal of Heart and Lung Transplantation, July 2022, Elsevier

    Joanna Pepke-Zaba

  24. Oral anticoagulants (NOAC and VKA) in chronic thromboembolic pulmonary hypertension

    Article • The Journal of Heart and Lung Transplantation, June 2022, Elsevier

    Joanna Pepke-Zaba

  25. Different Cytokine Patterns in BMPR2-Mutation-Positive Patients and Patients With Pulmonary Arterial Hypertension Without Mutations and Their Influence on Survival

    Article • CHEST Journal, June 2022, Elsevier

    Joanna Pepke-Zaba

  26. Prevalence and clinical impact of atrioventricular conduction disease in patients with idiopathic pulmonary arterial hypertension

    Article • European Heart Journal, October 2021, Oxford University Press (OUP)

    Joanna Pepke-Zaba

  27. ERS statement on chronic thromboembolic pulmonary hypertension

    Article • European Respiratory Journal, December 2020, European Respiratory Society (ERS)

    marion delcroix, Joanna Pepke-Zaba, Professor Olivier SITBON

  28. Plasma metabolomics in chronic thromboembolic pulmonary hypertension

    Article • September 2020, European Respiratory Society (ERS)

    Joanna Pepke-Zaba

  29. CAMPHOR score: patient-reported outcomes are improved by pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension

    Article • European Respiratory Journal, June 2020, European Respiratory Society (ERS)

    Joanna Pepke-Zaba

  30. The ADAMTS13–VWF axis is dysregulated in chronic thromboembolic pulmonary hypertension

    Article • European Respiratory Journal, January 2019, European Respiratory Society (ERS)

    Joanna Pepke-Zaba

  31. Response by Cannon and Pepke-Zaba to Letter Regarding Article, “Dynamic Risk Stratification of Patient Long-Term Outcome After Pulmonary Endarterectomy: Results From the United Kingdom National Cohort”

    Article • Circulation, October 2016, Wolters Kluwer Health

    Joanna Pepke-Zaba

  32. Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension

    Article • Circulation, March 2016, Wolters Kluwer Health

    Joanna Pepke-Zaba

  33. Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

    Article • Circulation, November 2011, Wolters Kluwer Health

    Joanna Pepke-Zaba

  34. Chronic Thromboembolic Pulmonary Hypertension

    Article • January 2009, Springer Science + Business Media

    Joanna Pepke-Zaba

  35. Pulmonary hypertension in patients with COPD: NO treatment?

    Article • Thorax, April 2003, BMJ

    Joanna Pepke-Zaba

  36. Endothelial dysfunction in vascular disease

    Article • The Lancet, November 1990, Elsevier

    Professor Anh Tuan Dinh-Xuan, Joanna Pepke-Zaba